FDA Approves Balversa for Metastatic Bladder Cancer

The FDA amended its approval for Balversa for the treatment of patients with locally advanced or metastatic bladder cancer.

Related Keywords

,Drug Administration ,Bladder Cancer ,Fda Approval ,News ,Balversa ,Erdafitinib ,